A biopharmaceutical company focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
The best Bull and Bear pitches based on recency and number of recommendations.
This is my one...my ONE feel good story in my CAPS portfolio. I've followed Immunomedics for roughly six years and I've liked the direction management has taken the company in each successive year. They have never tried to mislead investors or the… More
Surprisingly, my recent long bet on Immunomedics turned out to be a winner. Perhaps I have Trump to thank for that since I bought in shortly before the election surprise. Or perhaps I just got lucky: I've made a dozen bottom feeding picks in the last… More
Read the most recent pitches from players about IMMU.DL.
Find the members with the highest scoring picks in IMMU.DL.
See what the Wall Street professionals think, according to their public statements and filings.